E. hirae restored the efficacy of CTX in antibiotics-treated mice
E. hirae and B. intestinihominis enhanced cognate anticancer immune responses
NOD2 receptors limit the bioactivity of E. hirae and B. intestinihominis
CD4+ T cell responses against E. hirae are associated with survival in cancer patients